Sorry, your browser is out of date. To view this page correctly, please install a modern browser (Microsoft Edge, Firefox or Google Chrome).
SAI - Detailed view
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
SUNLENCA Inj Lös 463.5 mg/1.5ml 2 Durchstf 1.5 ml
Drug
Sunlenca, Injektionslösung
HIV-Infektion
08.03.0. – antivirals
HAM – Human medicine
LSINJ – Solution for injection
S – synthetic products for human use
A – Dispensed once only on prescription by a physician or veterinarian (A)
Z – approved
7/7/2023
7/6/2028
Dosage strength
Sunlenca, Injektionslösung
HIV-Infektion
01
Z – approved
Package
7680683850012
No information made available
A/R – Authorised / referenced
2 vial(s)
001
Z – approved
Declaration
Component
463.5 mg lenacapavirum
lenacapavirum natricum
lenacapavirum natricum
macrogolum 300
aqua ad iniectabile
10.99 mg natrium
aqua ad iniectabile
10.99 mg natrium
Authorisation holder
7601001379374
Gilead Sciences Switzerland Sàrl
General-Guisan-Strasse 8
6300 Zug (ZG)
General-Guisan-Strasse 8
6300 Zug (ZG)
Date of revision of the text
9/1/2023
Please log in as a company employee using your Swiss-Rx-Login. For further information please see the FAQ.
Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.